CHILDREN'S ALLEGRA ORAL SUSPENSION OTC
Generic Name and Formulations:
Fexofenadine HCl 30mg/5mL; contains sodium 18mg/5mL; raspberry flavor.
Indications for CHILDREN'S ALLEGRA ORAL SUSPENSION:
Allergic rhinitis (seasonal). Chronic idiopathic urticaria.
10mL every 12 hours; max 20mL/24hrs.
<2yrs: not recommended. ≥2yrs: 5mL every 12 hours; max 10mL/24hrs.
Pregnancy (Cat.C). Nursing mothers.
Avoid concomitant aluminum- or magnesium-containing antacids.
Adults: Headache, back pain, viral infection, GI upset, sinusitis, dizziness, drowsiness. Children: cough, fever, pain, otitis media, upper respiratory tract infection.
Tabs—6; ODT—6; Susp—4oz
Endocrinology Advisor Articles
- Soluble Klotho Levels Predictive of Kidney Failure in Type 2 Diabetes
- HbA1c Levels Predictive of Liraglutide Treatment Response in T2D
- Clinicians May Be Overtreating Older Patients With Diabetes
- Comorbid and Pharmacologic Factors Increase Risk for Gastrointestinal Disorders in Diabetes
- ADA Updates Guidelines for Cardiovascular Risk Management in Diabetes
- Autism Does Not Affect Metabolic Control in Type 1 Diabetes
- Hormonal Contraceptives May Adversely Affect Psychological Health in Adolescent Girls
- Obesity Can Negatively Effect Liver in Children as Young as 8
- Recommendations Developed on Gender Equity in Medicine
- Intensive Lifestyle Interventions Cut Long-Term Disability in Type 2 Diabetes